Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies. 2012

Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

OBJECTIVE To discover, elucidate the structure-activity relationship (SAR), and explore the mechanism of action of excipients able to drastically lower the viscosities of concentrated aqueous solutions of humanized monoclonal antibodies (MAbs). METHODS Salts prepared from hydrophobic cations and anions were dissolved into humanized MAbs solutions. Viscosities of the resulting solutions were measured as a function of the nature and concentration of the salts and MAbs. RESULTS Even at moderate concentrations, some of the salts prepared herein were found to reduce over 10-fold the viscosities of concentrated aqueous solutions of several MAbs at room temperature. CONCLUSIONS To be potent viscosity-lowering excipients, the ionic constituents of the salts must be hydrophobic, bulky, and aliphatic. A mechanistic hypothesis explaining the observed salt effects on MAb solutions' viscosities was proposed and verified.

UI MeSH Term Description Entries
D007477 Ions An atom or group of atoms that have a positive or negative electric charge due to a gain (negative charge) or loss (positive charge) of one or more electrons. Atoms with a positive charge are known as CATIONS; those with a negative charge are ANIONS.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D012965 Sodium Chloride A ubiquitous sodium salt that is commonly used to season food. Sodium Chloride, (22)Na,Sodium Chloride, (24)NaCl
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014783 Viscosity The resistance that a gaseous or liquid system offers to flow when it is subjected to shear stress. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Viscosities
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
December 2015, Molecular pharmaceutics,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
March 2011, Biotechnology and bioengineering,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
June 2025, Biophysical journal,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
November 2021, Journal of pharmaceutical sciences,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
January 2019, Scientific reports,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
September 2023, Molecular pharmaceutics,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
May 2017, Journal of pharmaceutical sciences,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
November 2022, Journal of molecular liquids,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
September 2015, Pharmaceutical research,
Zheng Guo, and Alvin Chen, and Roger A Nassar, and Bernhard Helk, and Claudia Mueller, and Yu Tang, and Kapil Gupta, and Alexander M Klibanov
July 1960, Nature,
Copied contents to your clipboard!